Latest & greatest articles for insomnia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on insomnia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on insomnia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for insomnia

361. Continuous positive airway pressure compared with oral devices or lifestyle changes for the treatment of obstructive sleep apnea: a review of the clinical and cost-effectiveness

Continuous positive airway pressure compared with oral devices or lifestyle changes for the treatment of obstructive sleep apnea: a review of the clinical and cost-effectiveness Continuous positive airway pressure compared with oral devices or lifestyle changes for the treatment of obstructive sleep apnea: a review of the clinical and cost-effectiveness Continuous positive airway pressure compared with oral devices or lifestyle changes for the treatment of obstructive sleep apnea: a review (...) of the clinical and cost-effectiveness CADTH Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Continuous positive airway pressure compared with oral devices or lifestyle changes for the treatment of obstructive sleep apnea: a review of the clinical and cost-effectiveness. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid

2014 Health Technology Assessment (HTA) Database.

362. Lariglutide injection for obesity: sleep apnea study (Saxenda)

patients were randomized (76.6%). Trial 3970 This was a 32-week trial designed to explore the effect of liraglutide on endpoints related to obstructive sleep apnea (OSA). Reviewer comment: During the ongoing NDA review, DMEP consulted the expertise of the Division of Neurology Products (DNP) for input regarding the sponsor’s study design and choice of endpoints. Key Inclusion Criteria ? BMI = 30 kg/m 2 ? Diagnosis of moderate or severe OSA (apnea-hypopnea index, AHI = 15) ? Unwilling or unable to use (...) obstructive sleep apnea (OSA). The sponsor proposes the following text for the INDICATIONS AND USAGE section of labeling: Saxenda is indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of ? 30 kg/m2 or greater (obese) (1) or Reference ID: 3645660Ronald Farkas, M.D., Ph.D., HFD-120 Medical Review Page 2 of 7 ? 27 kg/m2 or greater (overweight) in the presence of at least one weight related

2014 FDA - Drug Approval Package

363. CPAP versus oxygen in obstructive sleep apnea. Full Text available with Trip Pro

of cardiovascular risk.We conducted a randomized, controlled trial in which patients with cardiovascular disease or multiple cardiovascular risk factors were recruited from cardiology practices. Patients were screened for obstructive sleep apnea with the use of the Berlin questionnaire, and home sleep testing was used to establish the diagnosis. Participants with an apnea-hypopnea index of 15 to 50 events per hour were randomly assigned to receive education on sleep hygiene and healthy lifestyle alone (...) CPAP versus oxygen in obstructive sleep apnea. Obstructive sleep apnea is associated with hypertension, inflammation, and increased cardiovascular risk. Continuous positive airway pressure (CPAP) reduces blood pressure, but adherence is often suboptimal, and the benefit beyond management of conventional risk factors is uncertain. Since intermittent hypoxemia may underlie cardiovascular sequelae of sleep apnea, we evaluated the effects of nocturnal supplemental oxygen and CPAP on markers

2014 NEJM Controlled trial quality: predicted high

364. Review: recommendations for the assessment and management of sleep disorders in ADHD

Review: recommendations for the assessment and management of sleep disorders in ADHD Review: recommendations for the assessment and management of sleep disorders in ADHD | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: recommendations for the assessment and management of sleep disorders in ADHD Article Text Outcomes Review: recommendations for the assessment and management of sleep disorders in ADHD Statistics from

2014 Evidence-Based Mental Health

365. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. Full Text available with Trip Pro

Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. More than 70% of patients with resistant hypertension have obstructive sleep apnea (OSA). However, there is little evidence about the effect of continuous positive airway pressure (CPAP) treatment on blood pressure in patients with resistant hypertension.To assess the effect of CPAP treatment on blood pressure values and nocturnal blood pressure patterns (...) in patients with resistant hypertension and OSA.Open-label, randomized, multicenter clinical trial of parallel groups with blinded end point design conducted in 24 teaching hospitals in Spain involving 194 patients with resistant hypertension and an apnea-hypopnea index (AHI) of 15 or higher. Data were collected from June 2009 to October 2011.CPAP or no therapy while maintaining usual blood pressure control medication.The primary end point was the change in 24-hour mean blood pressure after 12 weeks

2013 JAMA Controlled trial quality: predicted high

366. CPAP Treatment for Adults with Obstructive Sleep Apnea

CPAP Treatment for Adults with Obstructive Sleep Apnea TITLE: CPAP Treatment for Adults with Obstructive Sleep Apnea: Review of the Clinical and Cost-Effectiveness and Guidelines DATE: 18 November 2013 CONTEXT AND POLICY ISSUES Obstructive sleep apnea (OSA) is a common disorder characterized by recurrent episodes of partial (hypopnea) or complete (apnea) upper airway obstruction during sleep despite ongoing respiratory efforts, resulting in disruption of sleep (arousal). 1 OSA affects 9 (...) % of middle-aged men and 3% of women in North America. 2 If left untreated, OSA can lead to fatigue, somnolence, headaches, cardiovascular disease, decreased quality of life, and increased risk of motor vehicle accidents. 2 The gold standard assessment for OSA is polysomnography, a test that measures neurologic and cardio-respiratory parameters during sleep. 1,2 The frequency of obstructive events measured during polysomnography is reported as the apnea-hypopnea index (AHI). 2 According to the American

2013 Canadian Agency for Drugs and Technologies in Health - Rapid Review

367. The remede® system for central sleep apnoea

The remede® system for central sleep apnoea The remede® system for central sleep apnoea The remede® system for central sleep apnoea NIHR HSC Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation NIHR HSC. The remede® system for central sleep apnoea. Birmingham: NIHR Horizon Scanning Centre (NIHR HSC). Horizon Scanning Review. 2013 Final (...) publication URL Indexing Status Subject indexing assigned by CRD MeSH Humans; Information Systems; Medical Records; Sleep Apnea, Central Language Published English Country of organisation England English summary An English language summary is available. Address for correspondence The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health&Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel

2013 Health Technology Assessment (HTA) Database.

368. Provent sleep apnea therapy (Ventus Medical Inc.) for obstructive sleep apnea

. Lansdale: HAYES, Inc.. Healthcare Technology Brief Publication. 2013 Authors' conclusions Obstructive sleep apnea (OSA) is a breathing disorder that is defined by either a decrease or complete cessation of airflow during sleep. Airflow obstruction arises when the muscles in the back of the throat fail to keep the airway open. OSA is characterized by repetitive pauses in breathing during sleep, despite the effort to breathe, and is usually associated with a reduction in blood oxygen saturation (...) . These pauses in breathing, called apneas, typically last 20 to 40 seconds. Hypopnea involves episodes of overly shallow breathing or an abnormally low respiratory rate. Hypopnea differs from apnea in that there remains some flow of air. Untreated OSA is associated with symptoms of sleep deprivation and excessive sleepiness, cognitive dysfunction, diminished quality of life and productivity, sexual dysfunction, mood changes, increased accident risk, and cardiovascular disease and stroke. OSA has

2013 Health Technology Assessment (HTA) Database.

369. A wake-up call on children’s well-being: do more, do it now

A wake-up call on children’s well-being: do more, do it now A wake-up call on children’s well-being: do more, do it now | Evidently Cochrane sharing the latest Cochrane Reviews Search Main menu Post navigation by It’s official – the Chief Medical Officer is ‘profoundly ashamed’. In her , Professor Dame Sally Davies highlights appalling inequalities in the UK, with three times as many child deaths in the poorest areas compared with wealthier regions, and shows us to be a nation lagging behind (...) for Health and Care Excellence. Managing overweight and obesity in children and young people: lifestyle weight management services. London: National Institute for Health and Care Excellence; 2013. NICE Public Health Guidance 47. [Issued October 2013]. Available: Neil Gaiman, The Sandman, Vol. 9: The Kindly Ones Advertisements Share this: Like this: Like Loading... Related This entry was posted in and tagged , , , , , , , , , , , , , , by . Bookmark the . 1 thought on “ A wake-up call on children’s well

2013 Evidently Cochrane

370. A wake-up call on children’s well-being: do more, do it now

A wake-up call on children’s well-being: do more, do it now A wake-up call on children’s well-being: do more, do it now | Evidently Cochrane sharing the latest Cochrane Reviews Search Main menu Post navigation by It’s official – the Chief Medical Officer is ‘profoundly ashamed’. In her , Professor Dame Sally Davies highlights appalling inequalities in the UK, with three times as many child deaths in the poorest areas compared with wealthier regions, and shows us to be a nation lagging behind (...) for Health and Care Excellence. Managing overweight and obesity in children and young people: lifestyle weight management services. London: National Institute for Health and Care Excellence; 2013. NICE Public Health Guidance 47. [Issued October 2013]. Available: Neil Gaiman, The Sandman, Vol. 9: The Kindly Ones Advertisements Share this: Like this: Like Loading... Related This entry was posted in and tagged , , , , , , , , , , , , , , by . Bookmark the . 1 thought on “ A wake-up call on children’s well

2013 Evidently Cochrane

371. Manipulating the sleep-wake cycle and circadian rhythms to improve clinical management of major depression

/79Table 1 Characteristic sleep-wake and circadian features of selected mood disorders Mood syndromes Sleep-wake and circadian features Major depression ? Subjective sleep-wake complaints (often preceding the onset or recurrence of depressive episodes) Difficulty falling asleep, staying asleep or early morning awakening [131,132] Disturbing dreams [133] Unrefreshing shallow sleep [132,134] Daytime fatigue and sleepiness [132,134,135] ? Macro and microarchitecture of sleep Abnormal sleep duration [136 (...) and mood deterioration [43,116] Bipolar disorders ? Characterized by episodic periods of sleep loss (that is, switching from wake to normal duration sleep state and back again over a 24-hour period) [191,192] ? High prevalence of hypersomnia, especially ‘morning hypersomnia’ [193-195] ? Insomnia often occurring before and during manic episodes [196] ? Insomnia or hypersomnia often occurring before and during depressive episodes [196] ? Macro and microarchitecture of sleep Depressive phase: longer sleep

2013 Clinical Practice Guidelines Portal

372. Zolpidem tartrate - Insomnia, short-term treatment

% CI: 0.02 to 14.43). ? There was no statistically significant difference in wake after sleep onset; MD of 1.13 minutes (95% CI: ?5.03 to 7.28). ? At least one adverse event was reported for 15.7% of patients treated with sublingual zolpidem and 22.9% of patients treated with oral zolpidem. Cost and Cost-Effectiveness The manufacturer submitted a cost minimization analysis comparing sublingual zolpidem with oral zopiclone for the short-term management of primary insomnia, based on the submitted (...) consecutive days, and that the use of hypnotics should be restricted for insomnia where disturbed sleep results in impaired daytime functioning. Zolpidem is available in 5 mg and 10 mg sublingual orally disintegrating tablets. The recommended dose for adults is 10 mg once daily immediately before bedtime. Summary of CDEC Considerations: The Committee considered the following information prepared by the Common Drug Review (CDR): a systematic review of sublingual zolpidem, a critique of the manufacturer’s

2013 Canadian Agency for Drugs and Technologies in Health - Common Drug Review

373. Management of Obstructive Sleep Apnea in Adults: A Clinical Practice Guideline From the American College of Physicians. Full Text available with Trip Pro

Management of Obstructive Sleep Apnea in Adults: A Clinical Practice Guideline From the American College of Physicians. The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the management of obstructive sleep apnea (OSA) in adults.This guideline is based on published literature from 1966 to September 2010 that was identified by using MEDLINE, the Cochrane Central Register of Controlled Trials, and the Cochrane Database (...) of Systematic Reviews. A supplemental MEDLINE search identified additional articles through October 2012. Searches were limited to English-language publications. The clinical outcomes evaluated for this guideline included cardiovascular disease (such as heart failure, hypertension, stroke, and myocardial infarction), type 2 diabetes, death, sleep study measures (such as the Apnea-Hypopnea Index), measures of cardiovascular status (such as blood pressure), measures of diabetes status (such as hemoglobin A1c

2013 Annals of Internal Medicine

374. Sleep clinical record: an aid to rapid and accurate diagnosis of paediatric sleep disordered breathing Full Text available with Trip Pro

. The sleep clinical record consists of three items: physical examination, subjective symptoms and clinical history. The clinical history analyses behavioural and cognitive problems. All three items were used to create a sleep clinical score (SCS). We studied 279 children, mean ± SD age 6.1 ± 3.1 years, 63.8% male; 27.2% with primary snoring and 72.8% with obstructive sleep apnoea (OSA) syndrome. The SCS was higher in the OSA syndrome group compared to the primary snoring group (8.1 ± 9.6 versus 0.4 ± 0.3 (...) Sleep clinical record: an aid to rapid and accurate diagnosis of paediatric sleep disordered breathing Overnight polysomnography (PSG) is an expensive procedure which can only be used in a minority of cases, although it remains the gold standard for the diagnosis of sleep disordered breathing (SDB). The objective of this study was to develop a simple, PSG-validated tool to screen SDB, thus reducing the use of PSG. For every participant we performed PSG and a sleep clinical record was completed

2013 EvidenceUpdates

375. Adult obstructive sleep apnoea. Full Text available with Trip Pro

Adult obstructive sleep apnoea. Obstructive sleep apnoea is an increasingly common disorder of repeated upper airway collapse during sleep, leading to oxygen desaturation and disrupted sleep. Features include snoring, witnessed apnoeas, and sleepiness. Pathogenesis varies; predisposing factors include small upper airway lumen, unstable respiratory control, low arousal threshold, small lung volume, and dysfunctional upper airway dilator muscles. Risk factors include obesity, male sex, age (...) , menopause, fluid retention, adenotonsillar hypertrophy, and smoking. Obstructive sleep apnoea causes sleepiness, road traffic accidents, and probably systemic hypertension. It has also been linked to myocardial infarction, congestive heart failure, stroke, and diabetes mellitus though not definitively. Continuous positive airway pressure is the treatment of choice, with adherence of 60-70%. Bi-level positive airway pressure or adaptive servo-ventilation can be used for patients who are intolerant

2013 Lancet

376. Inspire® Upper Airway Stimulation System for obstructive sleep apnoea

apnoea. Birmingham: NIHR Horizon Scanning Centre (NIHR HSC). Horizon Scanning Review. 2013 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Electric Stimulation Therapys; Sleep Apnea, Obstructive Language Published English Country of organisation England English summary An English language summary is available. Address for correspondence The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health&Population Sciences (...) Inspire® Upper Airway Stimulation System for obstructive sleep apnoea Inspire® Upper Airway Stimulation System for obstructive sleep apnoea Inspire® Upper Airway Stimulation System for obstructive sleep apnoea NIHR HSC Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation NIHR HSC. Inspire® Upper Airway Stimulation System for obstructive sleep

2013 Health Technology Assessment (HTA) Database.

377. Recommendations for the management of patients with obstructive sleep apnoea and hypertension

Recommendations for the management of patients with obstructive sleep apnoea and hypertension Options

2013 European Respiratory Society

378. Retesting Patients with Sleep Apnea

that met the inclusion criteria. 1 Retesting Patients with Sleep Apnea 2 REFERENCES SUMMARIZED Health Technology Assessments 1. Merlin T, Liufu Z, Wang S. Unattended sleep studies in the diagnosis and reassessment of obstructive sleep apnoea. Canberra (AU): Commonwealth of Australia; 2010. (MSAC application 1130, Assessment Report). [cited 2013 May 14]. Available from: http://www.msac.gov.au/internet/msac/publishing.nsf/Content/BAE45713D7D0FDEBCA25 7817001CB46D/$File/1130_MSAC_Report.pdf See (...) of childhood obstructive sleep apnea syndrome. Pediatrics. 2012 Sep;130(3):576-84. PubMed: PM22926173 3. Epstein LJ, Kristo D, Strollo PJ, Jr., Friedman N, Malhotra A, Patil SP, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009 Jun 15;5(3):263-76. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699173 PubMed: PM19960649 Additional References 4. Pre-operative screening and post-operative monitoring in adult

2013 Canadian Agency for Drugs and Technologies in Health - Rapid Review

379. Myofunctional Therapy May Reduce the Severity of Moderate Obstructive Sleep Apnea

consisting of 30 min daily exercises for the musculature of the soft palate, the tongue and the face as well as exercises involving breathing, speech, swallowing and chewing, the treatment group showed changes in many of the measured categories. The apnea-hypopnea index (AHI) decreased from 22.4± 4.8 to 13.7 ±8.5 events/hr (p=.007). There was also improvement in other sleep apnea indicators and symptoms such as a reduction in neck circumference (from 39.6 ± 3.6 to 38.5 ± 4.0 with p=.01), a decrease (...) Myofunctional Therapy May Reduce the Severity of Moderate Obstructive Sleep Apnea UTCAT2482, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Myofunctional Therapy May Reduce the Severity of Moderate Obstructive Sleep Apnea Clinical Question In patients diagnosed with moderate obstructive sleep apnea, does myofunctional therapy improve symptoms compared with no treatment? Clinical Bottom Line Myofunctional therapy may

2013 UTHSCSA Dental School CAT Library

380. Positional Therapy May Be Useful for Obstructive Sleep Apnea Patients Undergoing Orthodontic Dental Treatment

Positional Therapy May Be Useful for Obstructive Sleep Apnea Patients Undergoing Orthodontic Dental Treatment UTCAT2479, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Positional Therapy May Be Useful for Obstructive Sleep Apnea Patients Undergoing Orthodontic Dental Treatment Clinical Question For a 30 year old male with mild obstructive sleep apnea that is undergoing orthodontic treatment and unable to use the CPAP (...) AHI decreased from 26.7 ± 17.5 to 6.0 ± 3.4 with usage of the positional device during the first night test (T0) (p Evidence Search “Effectiveness of Positional Therapy for Obstructive Sleep Apnea” Comments on The Evidence Van Maanen conducted a case series on 31 patients with the use of a new sleep position trainer (SPT) for the treatment of positional obstructive sleep apnea. In this study, data that was collected from the SPT were manually reviewed for analysis by an experienced sleep

2013 UTHSCSA Dental School CAT Library